PI Pharma Insight

BNF presentation directory

Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.

Reset

Active filters

  • Product: Diclofenac sodium (Systemic)
Presentation Product Chemical substance Chapter Items dispensed
Diclofenac sodium 50mg gastro-resistant tablets
1001010C0AAAEAE
Diclofenac sodium (Systemic) Diclofenac sodium Musculoskeletal and Joint Diseases 48,783
Diclofenac 100mg suppositories
1001010C0AAACAC
Diclofenac sodium (Systemic) Diclofenac sodium Musculoskeletal and Joint Diseases 14,412
Diclofenac sodium 75mg modified-release capsules
1001010C0AAAWAW
Diclofenac sodium (Systemic) Diclofenac sodium Musculoskeletal and Joint Diseases 7,539
Diclofenac 50mg suppositories
1001010C0AAAUAU
Diclofenac sodium (Systemic) Diclofenac sodium Musculoskeletal and Joint Diseases 7,415
Diclofenac sodium 75mg modified-release tablets
1001010C0AAALAL
Diclofenac sodium (Systemic) Diclofenac sodium Musculoskeletal and Joint Diseases 7,172
Diclofenac sodium 25mg gastro-resistant tablets
1001010C0AAADAD
Diclofenac sodium (Systemic) Diclofenac sodium Musculoskeletal and Joint Diseases 4,686
Diclofenac sodium 75mg gast res MR caps
1001010C0AAARAR
Diclofenac sodium (Systemic) Diclofenac sodium Musculoskeletal and Joint Diseases 4,591
Diclofenac sodium 75mg gast res / Misoprostol 200microg tab
1001010C0AAAXAX
Diclofenac sodium (Systemic) Diclofenac sodium Musculoskeletal and Joint Diseases 2,328
Diclofenac sodium 50mg gast res / Misoprostol 200microg tab
1001010C0AAAMAM
Diclofenac sodium (Systemic) Diclofenac sodium Musculoskeletal and Joint Diseases 1,922
Diclofenac sodium 100mg modified-release capsules
1001010C0AAANAN
Diclofenac sodium (Systemic) Diclofenac sodium Musculoskeletal and Joint Diseases 1,715
Diclofenac sodium 100mg modified-release tablets
1001010C0AAAFAF
Diclofenac sodium (Systemic) Diclofenac sodium Musculoskeletal and Joint Diseases 1,600
Diclofenac 25mg suppositories
1001010C0AAATAT
Diclofenac sodium (Systemic) Diclofenac sodium Musculoskeletal and Joint Diseases 772
Diclofenac 75mg/3ml solution for injection ampoules
1001010C0AAAAAA
Diclofenac sodium (Systemic) Diclofenac sodium Musculoskeletal and Joint Diseases 229
Diclofenac 12.5mg suppositories
1001010C0AAABAB
Diclofenac sodium (Systemic) Diclofenac sodium Musculoskeletal and Joint Diseases 209
Diclofenac 50mg/5ml oral suspension
1001010C0AABLBL
Diclofenac sodium (Systemic) Diclofenac sodium Musculoskeletal and Joint Diseases 66
Diclofenac 75mg/1ml solution for injection ampoules
1001010C0AABMBM
Diclofenac sodium (Systemic) Diclofenac sodium Musculoskeletal and Joint Diseases 18
Diclofenac 50mg/5ml oral solution
1001010C0AAAVAV
Diclofenac sodium (Systemic) Diclofenac sodium Musculoskeletal and Joint Diseases 9
Diclofenac 100mg/5ml oral liquid
1001010C0AABJBJ
Diclofenac sodium (Systemic) Diclofenac sodium Musculoskeletal and Joint Diseases No data available
Diclofenac 10mg dispersible tablets
1001010C0AABBBB
Diclofenac sodium (Systemic) Diclofenac sodium Musculoskeletal and Joint Diseases No data available
Diclofenac 10mg/5ml oral liquid
1001010C0AABDBD
Diclofenac sodium (Systemic) Diclofenac sodium Musculoskeletal and Joint Diseases No data available
Diclofenac 12.5mg/5ml oral liquid
1001010C0AABCBC
Diclofenac sodium (Systemic) Diclofenac sodium Musculoskeletal and Joint Diseases No data available
Diclofenac 15mg/5ml oral liquid
1001010C0AABEBE
Diclofenac sodium (Systemic) Diclofenac sodium Musculoskeletal and Joint Diseases No data available
Diclofenac 25mg/5ml oral liquid
1001010C0AAAYAY
Diclofenac sodium (Systemic) Diclofenac sodium Musculoskeletal and Joint Diseases No data available
Diclofenac 40mg/5ml oral liquid
1001010C0AABKBK
Diclofenac sodium (Systemic) Diclofenac sodium Musculoskeletal and Joint Diseases No data available
Diclofenac 50mg dispersible tablets sugar free
1001010C0AAAJAJ
Diclofenac sodium (Systemic) Diclofenac sodium Musculoskeletal and Joint Diseases No data available

Why monitor BNF codes?

Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.

Track cost pressure

Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.

Understand demand drivers

Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.